Pfizer Worldwide Research & Development (WRD)
United States of America (USA)
1 June 2019 - 31 May 2020
Principal institution: Pfizer Inc.
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Pfizer Worldwide Research & Development (WRD) published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 17 | 3.55 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 9 | 0.88 | |
| Molecular Psychiatry | 2 | 0.01 | |
| Nature | 1 | 0.01 | |
| Nature Communications | 3 | 0.04 | |
| Nature Immunology | 1 | 0.23 | |
| Nature Structural & Molecular Biology | 1 | 0.38 | |
| eLife | 1 | 0.22 | |
| Chemistry | 8 | 2.67 | |
Top articles by Altmetric score in current window
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
Nature Communications
2020-01-09
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Nature Communications
2020-02-03
Subsets of ILC3−ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues
Nature Immunology
2019-06-17
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule
Nature Structural & Molecular Biology
2019-06-03
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
